ACOR - Acorda Therapeutics Inc. (ACOR) CEO Ron Cohen on Q3 2019 Results - Earnings Call Transcript
Acorda Therapeutics, Inc. (ACOR)
Q3 2019 Earnings Conference Call
November 5, 2019 04:30 p.m. ET
Company Representatives
Ron Cohen - Chief Executive Officer
Lauren Sabella - Chief Commercial Officer
David Lawrence - CTO, Chief of Business Operations & Principal Accounting Officer
Felicia Vonella - Vice President of Investor Relations
Conference Call Participants
Salveen Richter - Goldman Sachs
Nate Tower - Stifel
Neena Altaf - JPMorgan
Michael Yee - Jefferies
Kenneth Atkins - Cowen
Presentation
Operator
Welcome to the Acorda Therapeutics, Third Quarter 2019 Updates. At this time all participants are in a listen-only mode. There